Φορτώνει......
Macrophage migration inhibitory factor promotes resistance to glucocorticoid treatment in EAE
OBJECTIVE: Glucocorticoids (GCs) are used as standard treatment for acute attacks of multiple sclerosis (MS). However, GCs eventually lose efficacy and do not prevent disease progression. Macrophage migration inhibitory factor (MIF) is the only known proinflammatory cytokine induced by GCs that inhi...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Lippincott Williams & Wilkins
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4529283/ https://ncbi.nlm.nih.gov/pubmed/26280015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000139 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|